Petrackr deals with Chewy and Amazon
| Stock | Universal Biosensors Inc (UBI.ASX) |
|---|---|
| Release Time | 23 Jan 2025, 10:55 a.m. |
| Price Sensitive | Yes |
Universal Biosensors signs deals with Chewy and Amazon
- Signed Vendor Master Purchase Agreement with Chewy, one of USA's largest pet retailers
- Launched Petrackr on Amazon
- Deals with Chewy and Amazon are ongoing and can be terminated by either party with 30 days notice
Universal Biosensors, Inc. (ASX: UBI) has signed a Vendor Master Purchase Agreement with Chewy, Inc. (Chewy), one of the USA's largest pet retailers. Chewy recorded more than USD $11 billion in revenue in 2023 and has more than 20 million active customers. In addition to the Chewy deal, UBI has also launched Petrackr on Amazon. The deals with Chewy and Amazon are ongoing and can be terminated by either party with 30 days notice. UBI has been working with Chewy (and Amazon) for more than 9 months building its ecommerce capability to execute these agreements and begin making sales on the Chewy and Amazon platforms. UBI's initial focus for the launch of Petrackr was the professional vet network, but it has become apparent that the majority of sales for vet blood glucose monitoring systems are online. Chewy and Amazon are collectively the largest retailers of veterinary products in North America, and UBI expects the completion of these deals to have a material impact on Petrackr sales moving forward.
UBI expects the completion of the deals with Chewy and Amazon to have a material impact on Petrackr sales moving forward.